Announcements Trials

Browse Landscape

Phase

Status

Completed 32 Recruiting 4 Not yet recruiting 4 Unknown 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 73 Breast Neoplasms 73 Colorectal Neoplasms 39 Prostatic Neoplasms 37 Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 26 Uterine Cervical Neoplasms 20 Stomach Neoplasms 20 Carcinoma, Hepatocellular 20 Pancreatic Neoplasms 15 Anxiety Disorders 15 Leukemia, Myeloid, Acute 14 Hematologic Neoplasms 13 Colonic Neoplasms 13 Urinary Bladder Neoplasms 12 Lymphoma, Follicular 12 Brain Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Head and Neck Neoplasms 10 Esophageal Neoplasms 10 Diabetes Mellitus 10 Sarcoma 9 Ovarian Neoplasms 9 Melanoma 9 Liver Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Rectal Neoplasms 8 Pulmonary Disease, Chronic Obstructive 8 Epilepsy 8 Disease 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Medication Adherence × Clear all

NCT05948618 2026-03-04

ECA-PRO Aim 3

Tufts Medical Center

Phase NA Enrolling by invitation

Neoplasms, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡